The Effect of Honey on Lessening the Withdrawal Symptoms

March 2, 2022 updated by: Buddhist Tzu Chi General Hospital

The Effect of Honey on Lessening the Withdrawal Symptoms According to the Body Constitution

This project investigates the effect of honey on lessening the withdrawal symptoms according to the body constitution.

Study Overview

Study Type

Interventional

Enrollment (Anticipated)

100

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Locations

      • Hualien City, Taiwan, 970
        • Recruiting
        • Hualien Tzu Chi Hospital
        • Contact:
          • Chung-shan Hung, Ph.D
          • Phone Number: 17617 886-38561825

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • the cessation clinic patients aged more than 18
  • only take Champix for smoking cessation

Exclusion Criteria:

  • diabetes, cancer, renal disease
  • with wet and hot body constitution
  • allergic to honey
  • accepting traditional Chinese medicine intervention

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Experimental group
Participants need to drink honey every day for four weeks.
Participants need to drink honey every day for four weeks.
Placebo Comparator: Control group
Participants need to drink water every day for four weeks.
Participants need to drink water every day for four weeks.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Fagerstrom Test for Nicotine Dependence
Time Frame: Before and after the 4-week trial, 3 and 6 months after the trial
Change from baseline Fagerstrom Test for Nicotine Dependence at 4 weeks, 3 and 6 months after the trial. Fagerstrom Test for Nicotine Dependence is ranged from 0-10. The higher score the higher dependence on Nicotine.
Before and after the 4-week trial, 3 and 6 months after the trial
Minnesota Nicotine Withdrawal Scale
Time Frame: Before and after the 4-week trial
Change from baseline Minnesota Nicotine Withdrawal Scale at 4 weeks. The Minnesota Nicotine Withdrawal Scale is ranged from 0-84. The higher score indicates more severe withdrawal syndromes.
Before and after the 4-week trial

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Body Constitution Questionnaire
Time Frame: Before and after the 4-week trial
Change from baseline Body Constitution Questionnaire at 4 weeks. The Body Constitution Questionnaire contains 9 sub-scales, each is ranged from 0-100. The higher score indicates the likelihood of the body constitution.
Before and after the 4-week trial
Tobacco Craving Questionnaire
Time Frame: Before and after the 4-week trial
Change from baseline Tobacco Craving Questionnaire at 4 weeks. The Tobacco Craving Questionnaire contains 47 items that ranged from 1-7. The higher score indicates the higher craving for tobacco.
Before and after the 4-week trial
Depression Anxiety Stress Scales-21
Time Frame: Before and after the 4-week trial
Change from baseline Depression Anxiety Stress Scales-21 at 4 weeks. The Depression Anxiety Stress Scales-21 contains 3 sub-scales, each is scored form 0-28. The higher score indicates the more negative condition.
Before and after the 4-week trial
WHOQOL-BREF
Time Frame: Before and after the 4-week trial
Change from baseline WHOQOL-BREF at 4 weeks. WHOQOL-BREF contains 4 domains, each domain will be calculated to a score ranged from 0-100. The score of 100 indicates satisfaction of QOL.
Before and after the 4-week trial
Pittsburgh sleep quality index
Time Frame: Before and after the 4-week trial
Change from baseline Pittsburgh sleep quality index at 4 weeks. The Pittsburgh sleep quality index ranged from 0 to 21. The higher score indicates more severe difficulties in sleep.
Before and after the 4-week trial
Readiness to Quit Ladder
Time Frame: Before and after the 4-week trial
Change from baseline Readiness to Quit Ladder at 4 weeks. The Readiness to Quit Ladder is rated from 1 to 10. The higher score indicated better readiness to quit smoking.
Before and after the 4-week trial

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 3, 2021

Primary Completion (Anticipated)

February 28, 2023

Study Completion (Anticipated)

June 30, 2023

Study Registration Dates

First Submitted

February 11, 2022

First Submitted That Met QC Criteria

March 2, 2022

First Posted (Actual)

March 3, 2022

Study Record Updates

Last Update Posted (Actual)

March 3, 2022

Last Update Submitted That Met QC Criteria

March 2, 2022

Last Verified

February 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • P00001592

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Smoking Cessation

Clinical Trials on Honey

3
Subscribe